INTRODUCTION
The human platelet shares with other secretory cells a "phosphoinositide effect" (1, 2) , broadly defined as an alteration in the metabolism of phosphatidylinositol (PI)' preceding and paralleling secretion. In tissues such as pancreas, cerebral cortex, and parotid gland, stimulation by acetylcholinie elicits a breakdown of PI (3) (4) (5) . The secretory response of platelets is essenitially complete within 30 s (6) . Therefore, those chaniges in lipid metabolism that may participate in promoting secretioni must be well underway within this period. The rapid generation of cyclic endoperoxides derived from arachidonic acid released frolm PI and phosphatidylcholine (PC) is one such change (7) (8) (9) (10) . Additional short-term effects characterized thus far in platelets exposed to agents such as collagen, ADP, and thrombin have been an increased incorporation of [32P]orthophosphate into phosphatidic acid and polyphosphoinositides (11) and a decrease in the amount of previously radiolabeled PI (12) .
This report describes a rapid, transient generation of diglyceride in human platelets exposed to throinbin. Evidence is presented as well for the existence of a PI-specific phosphodiesterase in platelets which re-(juires calcium ions for full activity and which may be involved in the turnover of PI associated with the secretory process.
Inhibitors of platelet cyclo-oxygenase, such as acetylsalicylic acid, have iminimal effect on the release reaction induced by thrombin, however, N6-02'-dibutyryl cyclic AMP (dBcAMP) prevents such release. The production of diglyceride by platelets was examined in thp presence of acetylsalicylic acid and in the presence of dBcAMP in order to dissociate, if possible, the production of diglyceride from that of cyclic endoperoxides. The postthrombin formation of diglyceride appears to correlate with the occurrence of secretion, rather than with cyclic endoperoxide production.
METHODS
Preparation of cells and resolution of lipids. Platelet concentrates were provided by the Red Cross, within 24 h of phlebotomy, from normal donors. In some cases, blood was drawn in the laboratory from normal human volunteers and anticoagulated with acid-citrate-dextrose (13) . After a preliminary centrifugation at 150 g for 1 min (platelet concenr Clinical Investigation, Inc. 0021-9738/79/04/0580/08 $1.00
Volume 63 April 1979 580-587 trates) or 150 g for 15 min (whole blood), platelet-rich plasmla (PRP) was mixed wvith EGTA to a final conicenitrationi of 1 mM. For studies on the metabolismn of radiolabeled arachi(loniic acid or glycerol, PRP was incuibated with [5,6,8,9,11,12,14,15-3H] arachidonic acid (12.5 ,uCi/30 ml PRP, 72 Ci/mmol) which had been hound to albuumin as described previously (14) (8, 19) . Radioactivity contained in the lipid spots wvas counted by scintillationi spectrophotometry in H20-AqIuasol (New England Nuclear) (8) , and lipid phosphorus was assayed after dligestioni of parallel samiiples (19) . Neutral lipids were resolved by thin-laver chromatography in solvent systems I and II. DG spots were charred, counted, or digestedl bv KOH in MIeOH as described, and rechromiiatographed. The altered distril)ution of radliolabeled material in 12-visualized spots wvas (letermiinledl.
Platelets whose lipidls 'vere labeled with [3H]glycerol-were also incubated as described for [3H]arachidonic acid-labeled cells. The effect of thrombin on the release of ['4C]5-hvldroxytryptamine from labeled platelets was also determiinled in the presenice and absence of clBcAMP or ASA. Incubations were stopped with 2 vol of ice-cold buffer (15), pH 6.5, conitainiing imipramnine (6.7 ,u\M) anid EGTA (5 mnM). Cells were sedimented at 2,500 g for 5 min at 4°C, and the release of 14C-labeled material to the medium vwas assessed by scintillationi counting.
Phospholipid phosphodiesterase assays. Washed platelets describedl above were suspended to a concentrationi of 3 x 109 cells/ml in buffer (15) conitaining 5 mnM EGTA, pH 6.5. Platelet suspensions were soniicated in an ice-water bath wvith a microprobe for periods of 15 s. The total sonication timne was 2 min. Similarly, suspensions of erythrocytesneutrophils (3 x 105 cells/nil) were sonicated. Sonicates were spun at 100,000 g for 60 min at 4°C, and the supernatant solutioni was used in subsequenit incubationis.
Substrates Assays for phosphatide phosphodiesterase activity contained Na deoxycholate (2.1 mg/ml) or Triton X-100 (1 mg/ ml; Rohm and Hass Co., Philadelphia, Pa.); CaCl2 (0-10mM), 50 mM KCI, 21 nmol [3H]myoinositol PI, [14C]choline PC, PE, or PS, and up to 0.2 mg supematant protein (fresh or heated at 100°C for 5 min) in a final volume of 200 ,ul. Some mixtures contained 10 mM NaF. Incubations continued for up to 60 min at 37°C, and were terminated by the addition of 1.0 ml CHCl3:MeOH:HCl (100:100:0.6) and 0.3 ml 1 N HCl/5 mM EGTA. Part of the upper aqueous phase was assayed for radioactivity by scintillation spectrophotometry in H20-Aquasol (8) . Other portions of the upper phase were applied to silica papers and chromatographed in two directions as before (8) . The distribution of radiolabel among lyso-PI, inositol, and any PI present was determined for incubations that had included [3H]myoinositol PI. Samples of the [3H]myoinositol aqueous phase were also applied to Whatman no. 1 paper (Whatman, Inc., Clifton, N. J.) and resolved by descending chromatography in EtOH: 13.5 M NH3 (3:2) as described by Dawson and Clarke (21) 
RESULTS

Metabolic studies on intact cells
Time-dependent changes in human platelet phospholipids induced by thrombin. The production of DG by platelets exposed to 0.17 U thrombin/108 platelets was rapid. As illustrated in Fig. 1, within 5 s, 69% of the maximum amount of DG produced by the cell had been generated. The Contrasting effects of dBcAMP and ASA. Table II shows the effect of prior incubation of platelet suspensions with dBcAMP (2 mM) or ASA (100 ,ug/ml) on serotonin release and DG production as well as on the generation of [3H]arachidonic acid-labeled products arising ultimately from cyclo-oxygenase activity. It is seen that 1)oth dBcANIP and ASA effectively eliminated the formation of such arachidonic acid products, ordinarily generated in response to thrombin. However, only dBcANIP inhibited serotonini secretion and DG production as well. It was also noted sonicates to water-soluble labeled material and DG was dependent upon the presence of both deoxycholate (DOC) and Ca+2. The presence of 10 mM NaF affected neither the production of DG nor that of water-soluble material. In the absence of both DOC and Ca+2, no hydrolytic activity was detectable Omission of either DOC or Ca+2 from the incubation resulted in little activity. Triton X-100 could not substitute for DOC. Activity was not detectable when supernate that had been heated at 100°C for 5 min was employed.
The hydrolysis of [3H]myoinositol PI with time is shown in Fig. 4 . The dependency of the enzymatic activity upon Ca+2 is illustrated in Fig. 5 . Simulation by Ca+2 was optimal at 5 mM, whereas 10 Fig. 6 represents the relationship of the hydrolytic activity to the pH of the incubation mixture, displayed in the presence of 2 mg/ml DOC and 5 mM Ca+2. There was a clear optimum at pH 7 for both the generation of water-soluble radioactivity (represented in terms of nanomoles of [3H]myoinositol PI hydrolyzed) and the formation of DG. If one takes the molecular weight of chicken liver microsome PI-derived DG to be 590 (liver PI is considerably less rich in arachidonic acid than is human platelet PI; 26), then it is possible to calculate that the amount of DG produced on a molar basis is comparable both to the amount of [3H]myoinositol PI hydrolyzed and to the amount of water-soluble [3H]myoinositol-containing product formed, with a molar ratio of 0.99+0.14 (SE): 1.0. 
DISCUSSION
The production of DG appears to be one of the earliest metabolic events to occur during the activation of human platelets by thrombin, anteceding the full secretory response. The identification of DG as such is supported by the presence of alkali-hydrolyzable fatty acid and glycerol, and the observed comigration with known 1,2-DG in two different neutral lipid chromatography systems. Resting platelets contain very small quantities of DG (27) . Exposure of platelets to thrombin induces as much as a 30-fold increase in the amount of this material, but the elevation is transitory. Within 2 min, the platelet has essentially achieved the low levels of DG that characterize the resting state.
The source of the DG is most probably PI. Of the other possible candidates for precursor, TG, PA, phospholipid(s) other than PI, and monoglyceride, none is a satisfactory alternative. TG levels do not change significantly during the short time interval of relevance, nor does the content of [3H]arachidonic acid in TG decrease. PA, although difficult to quantitate on a mass basis, does not lose [3H]arachidonic acid with 15 s of exposure to thrombin, but rather, gains this fatty acid. Further, the presence of NaF, which has been shown to inhibit phosphatidate phosphatase (20) (21) , does not inhibit the production of DG. The formation of DG from PC, PS, or PE would require the action of a phosphatide phosphodiesterase acting upon one or all of these substrates. Thus far, Ino such activity has been detectable in humain platelets (28 (8, 10) . The specific activity of DG is slightly (15%) greater than that of PI, which in turn has a higher specific activity than PC, PS, and PE. Finally, the existence of a PI phosphodliesterase, described here, couldl accounit for the early changes observed.
The data presented in this report constitute direct evidence for a PI-specific phosphodiesterase in human platelets. It appears that the enzyme is a phospholipase C, producing myoinositol-l-phosphate and DG. Whether or not a myoinositol-1:2-cyclic phosphate is generated in the system, as is the case in certain other cells (21) , is unknown because the acidic conditions employed would cause a hydrolysis of the labile cyclic compound to the monoester form.
The existence of platelet PI-phosphodiesterase, and further, its requirement for Ca+2 at physiologic pH, are of interest for the elucidation of a secretory mechanism in platelets. The platelet contains large stores of sequestered Ca+2 which are apparently mobilized in the cytoplasm during the earliest stages of platelet activation (29) (30) (31) . Stimulation by a secretion-inducing agent such as thrombin might promote the hydrolysis of PI by making Ca+2 available to PI-phosphodiesterase. If the activation of PI-phosphodiesterase is an early event in the sequence leading to secretion by platelets, as it appears to be, it may provide another control point for platelet functioning and would thus merit investigation in human subjects displaying secretory defects.
The elevation of DG and the release of 5-HT from storage granules are similarly responsive to increased doses of thrombin. Under conditions in which secretioninducing arachidonic acid oxidation products are not formed, both the generation of DG and secretion in response to thrombin are unimpaired. Thus it appears that the increase in DG is not dependent upon the generation of prostaglandin endo-peroxides, which is blocked by aspirin. However, dBcAMP, which is thought to act, in part, to restrict Cal2 mobilization in platelets (32, 33) , effectively inhibits both secretion and DG formation.
The role of DG in the secretory process is as yet unknown. The level of DG has been shown to increase in certain other tissues during secretion (34) (35) (36) (37) , and Allan and Michell have suggested that DG promotes membrane fusibility in such processes (35) . Under certain conditions, DG facilitates fusion of hen erythrocytes (38) . Demel et al. (39) reported that the generation of DG in PC monolayers by phospholipase C lowered surface pressures, thereby promoting the breakdown ofthe monolayers. And recently, Chap et al. (40) observed that the production of diacylglycerols in platelet membranes exposed to Clostridium welchii phospholipase C was followed by aggregation and cell lysis.
It is thus possible that localized DG generated in platelet membranes may assist secretion by promoting the fusion of membranes.
